Ares Capital CorporationMultiple analysts cut price targets and fair value estimate, citing limited upside and risks to earnings and dividend coverage.

Ares Capital's fair value estimate has been reduced from about $22.64 to roughly $20.77 in one model, reflecting more cautious analyst sentiment. Wells Fargo downgraded the stock to Equal Weight from Overweight and lowered its price target to $19 from $20, citing richer valuations and limited upside. Other firms including B. Riley, Citizens, and Keefe Bruyette also trimmed their price targets, while Wells Fargo highlighted risks that continued non-accruals and restructurings could pressure net operating income and dividend coverage. The revised fair value model assumes revenue growth of about 1.55%, down from 3.42%, a net profit margin of roughly 46.99%, up from 44.58%, a future P/E of about 13.51 times, down from 17.46 times, and a discount rate of roughly 9.24%, down from 9.80%.
Ares Capital CorporationMultiple analysts cut price targets and fair value estimate, citing limited upside and risks to earnings and dividend coverage.
Wells Fargo & Company